SMARCB1 and neoplasm: SMARCB1 deficiency has been described in carcinomas of the gastro-entero-pancreatic tract, the head and neck region and in neoplasms of the genitourinary tract, representing a broad histomorphologic spectrum and polyphenotypic variations14.